Lobe Sciences Financials
| LOBEF Stock | USD 0 0.0003 20.00% |
With this module, you can analyze Lobe financials for your investing period. You should be able to track the changes in Lobe Sciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Lobe |
The data published in Lobe Sciences' official financial statements typically reflect Lobe Sciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Lobe Sciences' quantitative information. For example, before you start analyzing numbers published by Lobe accountants, it's essential to understand Lobe Sciences' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Lobe Sciences Stock Summary
Lobe Sciences competes with C21 Investments, Ascend Wellness, and Grey Cloak. Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 1199 West Hastings |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.lobesciences.com |
| Currency | USD - US Dollar |
Lobe Sciences Key Financial Ratios
There are many critical financial ratios that Lobe Sciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lobe Sciences reports annually and quarterly.| Return On Equity | -2.8 | |||
| Return On Asset | -0.65 | |||
| Beta | 2.64 | |||
| Z Score | -6.6 |
Lobe Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lobe Sciences's current stock value. Our valuation model uses many indicators to compare Lobe Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lobe Sciences competition to find correlations between indicators driving Lobe Sciences's intrinsic value. More Info.Lobe Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lobe Sciences' earnings, one of the primary drivers of an investment's value.Lobe Sciences Systematic Risk
Lobe Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lobe Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Lobe Sciences correlated with the market. If Beta is less than 0 Lobe Sciences generally moves in the opposite direction as compared to the market. If Lobe Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lobe Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lobe Sciences is generally in the same direction as the market. If Beta > 1 Lobe Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Lobe Sciences December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lobe Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lobe Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lobe Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Lobe OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lobe Sciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 48.43 | |||
| Information Ratio | 0.3034 | |||
| Maximum Drawdown | 1266.55 | |||
| Value At Risk | (90.40) | |||
| Potential Upside | 892.31 |
Complementary Tools for Lobe OTC Stock analysis
When running Lobe Sciences' price analysis, check to measure Lobe Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lobe Sciences is operating at the current time. Most of Lobe Sciences' value examination focuses on studying past and present price action to predict the probability of Lobe Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lobe Sciences' price. Additionally, you may evaluate how the addition of Lobe Sciences to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |